Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
A Randomized Phase III Trial of Thalidomide and...
Journal article

A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial

Abstract

Abstract Abstract 39

Authors

Stewart AK; Trudel S; Bahlis NJ; White DJ; Sabry W; Belch A; Reiman T; Roy J; Shustik C; Kovacs MJ

Journal

Blood, Vol. 116, No. 21,

Publisher

American Society of Hematology

Publication Date

November 19, 2010

DOI

10.1182/blood.v116.21.39.39

ISSN

0006-4971